contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


terveystalo-oyj-terveystalo-acquires-silmasairaala-pilke-oy-and-turun-silmalaser-oy-strengthens-position-in-eye-surgery

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

If you can’t access Arvopaperi, here is the press release:                   Inderes              Terveystalo Oyj: Terveystalo ostaa Silmäsairaala Pilke Oy:n ja Turun...    Terveystalo Oyj, lehdistötiedote, 7.1.2026Terveystalo Healthcare Oy allekirjoitti 3.12.2025 sopimukset kahdesta osakekaupasta, joiden myötä Silmäsairaala Pilke Oy ja Turun Silmälaser Oy (yhdess...                             The companies’ combined revenue in 2024 was approximately EUR 8.2 million and Terveystalo’s corresponding revenue was approximately EUR 1.3 billion, so it is likely safe to say that this won’t require any major measures. However, the release states the following: “The acquisition supports Terveystalo’s strategy to grow in specialized medical care and strengthens its position in the ophthalmic surgery market. Through the acquisition, Terveystalo gains access to new expertise, a wider network of clinics, and modern surgical technology, enabling a higher volume of cataract, lens, and refractive surgeries than before.”

Something like this in Arvopaperi magazine today

Here are Roni’s comments regarding how upper respiratory tract infection diagnoses are at a lower level than the comparison period. According to Terveystalo’s open reporting data, the upper respiratory tract infection diagnoses made by the company have been at a significantly lower level in the latter part of the year compared to the corresponding period last year, although the decrease is partly explained, in our assessment, by the company’s shrunken occupational health customer base. For both Terveystalo and Pihlajalinna, the “flu season” is one of the earnings drivers in Q4 and Q1, but in our view, its significance for the long-term development of the investment cases should not be overemphasized. In our assessment, achieving the guidance for the current year requires a strong end to the year from both, and the development of the flu season may become a decisive factor in terms of reaching the guidance.                   Inderes              Ylähengitystieinfektiot vertailukautta matalammalla tasolla - Inderes    Terveystalon avoimen raportoinnin datan mukaan yhtiön tekemät ylähengitystieinfektiodiagnoosit ovat olleet loppuvuodesta selvästi viime vuoden vastaavaa ajanjaksoa matalammalla tasolla, joskin laskua selittää osaltaan arviomme mukaan myös yhtiön...

Here is the full release.                    Inderes              Terveystalo Oyj: Sisäpiiritieto: Terveystalo ostaa Hohde Groupin - Inderes    Terveystalo Oyj SISÄPIIRITIETO 23.12.2025 klo 8.00 Terveystalo Healthcare Oy ("Terveystalo") allekirjoitti tänään 23.12.2025 sopimuksen Hammas Hohde Oy ja Loisto Laboratoriot Oy -yhtiöistä koostuvan...                             And here are the analyst’s comments.                    Inderes              Terveystalo ostaa suunterveyteen keskittyneen Hohde Groupin - Inderes    Toteutuessaan kauppa vahvistaisi merkittävästi Terveystalon suunterveyden palveluita, joissa yhtiö on hakenut voimakasta kasvua.

Here are Roni’s comments on Terveystalo signing an agreement to sell Sauma Lastensuojelupalvelut Oy to Validia Oy.  The sale did not come as a surprise, as the company has openly communicated that it is critically reviewing non-strategic and non-synergistic holdings within its Portfolio businesses, and we consider the divestment a sensible move in terms of strategic focus. The transaction has only a minor impact on Terveystalo’s figures, and we do not see it having an impact on the company’s investment story or our view.                   Inderes              Terveystalo divestoi lastensuojeluliiketoimintansa - Inderes    Terveystalo tiedotti perjantaina allekirjoittaneensa sopimuksen Sauma Lastensuojelupalvelut Oy:n myymisestä Validia Oy:lle.

Terveystalo

Terveystalo Plc, press release, 7 January 2026Terveystalo Healthcare Plc signed agreements on 3 December 2025 to acquire all shares in Silmäsairaala Pilke Oy and Turun Silmälaser Oy (collectively...

Terveystalo Plc, press release, 7 January 2026Terveystalo Healthcare Plc signed agreements on 3 December 2025 to acquire all shares in Silmäsairaala Pilke Oy and Turun Silmälaser Oy (collectively "Silmäsairaala Pilke"). The transactions were completed on 31 December 2025.Silmäsairaala Pilke provides ophthalmology services, eye examinations, and advanced surgical procedures, including cataract, lens, and refractive surgeries, primarily for private customers. In 2024, the companies' combined revenue was approximately EUR 8.2 million. Silmäsairaala Pilke employs around 35 professionals and operates in seven locations: Helsinki, Espoo, Turku, Tampere, Jyväskylä, Oulu and Vaasa. Operations will continue at their current premises, and all personnel will transfer to Terveystalo under existing employment terms.The acquisition supports Terveystalo's strategy to grow in specialised care and strengthens its position in the eye surgery market. Through the transaction, Terveystalo gains new expertise, an expanded network of clinics and access to modern surgical technology, enabling a higher volume of cataract, lens and refractive procedures."We are delighted to welcome the skilled teams of Silmäsairaala Pilke and Turun Silmälaser to Terveystalo. This acquisition significantly enhances our eye surgery offering, bringing us new locations and increased surgical capacity. Together, we can provide customers with even more comprehensive and high-quality ophthalmology services," says Tiina Tissari, Senior Vice President of Consumer and Insurance businesses and Specialities at Terveystalo."We are pleased that Silmäsairaala Pilke's operations will become part of Terveystalo, which is renowned for its high-quality specialised care and strong service network. Our customers will continue to receive excellent care. Within a larger organisation, our professionals will have the best possible opportunities to develop in their field," says Janne Järvenpää, specialist in ophthalmology at Silmäsairaala Pilke. Further information &nbsp;Terveystalo Tiina Tissari, Senior Vice President, Consumer and Insurance businesses and Specialities tiina.tissari@terveystalo.com Tel. +358 40 7193 518Silmäsairaala Pilke Janne Järvenpää, MD, Specialist in Ophthalmology, Eye Surgeon, MBA Tel. +358 10 5088 100 janne@silmäsairaalapilke.fi<div></div>